CAH 📈 Cardinal Health - Overview
Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US14149Y1082
CAH: Pharmaceuticals, Medical Supplies, Surgical Products, Gloves, Needles, Syringes
Cardinal Health Inc, a multinational healthcare services and products company, operates across the globe, with a presence in the United States, Canada, Europe, Asia, and other international markets. The company provides tailored solutions to a diverse range of customers, including hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients receiving care in their homes. By offering a broad portfolio of products and services, Cardinal Health aims to improve the efficiency and effectiveness of healthcare delivery.
The company's operations are organized into two primary segments: Pharmaceutical and Specialty Solutions, and Global Medical Products and Distribution. The Pharmaceutical and Specialty Solutions segment focuses on distributing a wide range of pharmaceutical products, including branded and generic medications, specialty pharmaceuticals, and over-the-counter healthcare and consumer products. Additionally, this segment provides specialized services to pharmaceutical manufacturers and healthcare providers, such as pharmacy management services for hospitals and repackaging of generic pharmaceuticals and over-the-counter healthcare products.
In the Global Medical Products and Distribution segment, Cardinal Health manufactures, sources, and distributes a vast array of medical, surgical, and laboratory products, including exam and surgical gloves, needles, syringes, and sharps disposals. The company also offers a range of compression, incontinence, nutritional delivery, and wound care products, as well as single-use surgical drapes, gowns, and apparel products. Furthermore, Cardinal Health distributes national brand products, provides supply chain services and solutions to healthcare providers, and assembles and sells sterile and non-sterile procedure kits.
Cardinal Health's product portfolio is complemented by its radiopharmaceutical manufacturing, preparation, delivery, and distribution capabilities, which cater to the needs of healthcare providers and patients. The company also leverages integrated technology solutions to optimize direct shipments and streamline its logistics operations. With a history dating back to 1979, Cardinal Health is headquartered in Dublin, Ohio, and has established itself as a leading player in the healthcare distribution industry, with a strong online presence at https://www.cardinalhealth.com.
As a publicly traded company listed on the New York Stock Exchange (NYSE) under the ticker symbol CAH, Cardinal Health's common stock is classified under the GICS Sub Industry of Health Care Distributors, with the ISIN code US14149Y1082. This classification reflects the company's core business activities and its position within the broader healthcare industry. By providing a wide range of products and services to healthcare providers and patients, Cardinal Health plays a critical role in supporting the delivery of high-quality patient care.
Additional Sources for CAH Stock
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
CAH Stock Overview
Market Cap in USD | 28,952m |
Sector | Healthcare |
Industry | Medical Distribution |
GiC Sub-Industry | Health Care Distributors |
IPO / Inception | 1987-12-31 |
CAH Stock Ratings
Growth 5y | 91.6% |
Fundamental | 41.2% |
Dividend | 48.0% |
Rel. Strength Industry | 446 |
Analysts | 3.65/5 |
Fair Price Momentum | 135.68 USD |
Fair Price DCF | 113.42 USD |
CAH Dividends
Dividend Yield 12m | 1.63% |
Yield on Cost 5y | 4.34% |
Annual Growth 5y | -4.84% |
Payout Consistency | 95.3% |
CAH Growth Ratios
Growth Correlation 3m | 53.1% |
Growth Correlation 12m | 59% |
Growth Correlation 5y | 92.6% |
CAGR 5y | 21.65% |
CAGR/Mean DD 5y | 2.67 |
Sharpe Ratio 12m | 0.70 |
Alpha | 0.38 |
Beta | 0.71 |
Volatility | 24.21% |
Current Volume | 2375.9k |
Average Volume 20d | 2177.3k |
As of January 15, 2025, the stock is trading at USD 124.03 with a total of 2,375,868 shares traded.
Over the past week, the price has changed by +1.03%, over one month by +2.78%, over three months by +8.45% and over the past year by +15.73%.
Partly, yes. Based on ValueRay Fundamental Analyses, Cardinal Health (NYSE:CAH) is currently (January 2025) ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 41.19 and therefor a somewhat positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of CAH as of January 2025 is 135.68. This means that CAH is currently overvalued and has a potential downside of 9.39%.
Cardinal Health has received a consensus analysts rating of 3.65. Therefor, it is recommend to hold CAH.
- Strong Buy: 5
- Buy: 2
- Hold: 9
- Sell: 1
- Strong Sell: 0
According to ValueRays Forecast Model, CAH Cardinal Health will be worth about 148.2 in January 2026. The stock is currently trading at 124.03. This means that the stock has a potential upside of +19.45%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 130.6 | 5.3% |
Analysts Target Price | 129.7 | 4.6% |
ValueRay Target Price | 148.2 | 19.5% |